UBS rates AGO as a buy, now that it has abandoned its plans for a tie-up with Aurizon. UBS suggests a deal with FMG is the best outcome and depending on the deal they think there could be as much as 1% valuation upside from the move.
Their target price is $1.40.
Add to My Watchlist
What is My Watchlist?